Market Tracker

07/29 5:16pm ET

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

26.53
Delayed Data
As of Jul 29
 -0.06 / -0.23%
Today’s Change
17.92
Today|||52-Week Range
70.40
-12.12%
Year-to-Date
Steven Cohen Buys AMAG Pharmaceuticals
Jul 29 / GuruFocus News - Paid Partner Content
Today's Perilous Reversal Stock: AMAG Pharmaceuticals (AMAG)
Jul 28 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close26.59
Today’s open26.68
Day’s range26.16 - 26.86
Volume372,430
Average volume (3 months)1,021,578
Market cap$917.4M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-82.73%
Earnings growth (this year)+465.09%
Earnings growth (next 5 years)-1.75%
Revenue growth (last year)+236.28%
P/E ratio74.0
Price/Sales2.55
Price/Book0.99

Competitors

 Today’s
change
Today’s
% change
VIVOMeridian Bioscience ...-0.64-3.20%
QDELQuidel Corp-0.44-1.89%
NTRANatera Inc-0.18-1.36%
--Quidel Corp+1.94+10.41%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)$1.22
Annual revenue (last year)$418.3M
Annual profit (last year)$32.8M
Net profit margin7.84%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
William K. Heiden
President &
Chief Operating Officer
Frank E. Thomas
Corporate headquarters
Waltham, Massachusetts

Forecasts